...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International journal of immunopathology and pharmacology. >Retrospective observational study to investigate Sinerga, a multifactorial nutritional product, and bacterial extracts in the prevention of recurrent respiratory infections in children
【24h】

Retrospective observational study to investigate Sinerga, a multifactorial nutritional product, and bacterial extracts in the prevention of recurrent respiratory infections in children

机译：回顾性观察性研究，旨在研究Sinerga（一种综合营养产品）和细菌提取物在预防小儿反复呼吸道感染中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In this retrospective observational clinical study, 167 children, aged 3 to 7 years, of both sexes, with a clinical history of recurrent respiratory infections, administered with bacterial extracts of first and second generation or Sinerga a nutritional product containing palmitoylethanolamide, bovine colostrum, phenylethylamine and the new generation of probiotic kluyveromyces FM B0399, were observed. The goal of the study was to compare the supplementation with Sinerga with the supplementation with bacterial extracts, for the effect on the frequency of episodes of respiratory infection that had resulted in a prescription for antibiotics. The study focused retrospectively on the months from March 2013 to November 2012. The results showed a greater reduction in the frequency of respiratory infections with antibiotic therapy in the group of children supplemented with Sinerga than in the group treated with bacterial extracts. In particular, it was observed that 49.3% of the children supplemented with Sinerga, against 5% of those supplemented with extracts, had no infectious episodes requiring the administration of an antibiotic. 100% of subjects supplemented with Sinerga have had no more than two episodes of respiratory infection, while this condition, in the cohort treated with bacterial extracts, was observed in only 51 % of cases.
机译：在这项回顾性观察性临床研究中，对167例年龄在3至7岁的男女儿童进行了反复呼吸道感染的临床病史，并给予第一代和第二代细菌提取物或Sinerga营养产品，其中含有棕榈酰乙醇酰胺，牛初乳，苯乙胺并观察到了新一代益生菌克鲁维酵母FM B0399。这项研究的目的是将补充Sinerga与补充细菌提取物的效果进行比较，以比较导致开具抗生素处方的呼吸道感染发作频率的影响。该研究回顾了2013年3月至2012年11月的几个月。结果显示，补充了Sinerga的儿童组与接受细菌提取物的组相比，抗生素治疗的呼吸道感染发生率降低了更多。尤其是，观察到补充了Sinerga的儿童中有49.3％的儿童没有感染性发作，而补充了提取物的儿童中却只有5％。 100％补充了Sinerga的受试者发生的呼吸道感染不超过两次，而在用细菌提取物治疗的人群中，仅51％的病例出现了这种情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号